secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inspire Medical Systems, Inc. (INSP)
CIK:        0001609550
Form:       8-K
Filed at:   2025-02-10T23:59:59+00:00
Accession:  0001609550-25-000009
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inspire Medical Q4 revenue $239.7M (+25% YoY); EPS $1.15; guides FY2025 rev $940-955M
--------------------------------------------------------------------------------

- Q4 revenue $239.7M (+25% YoY); net income $35.2M, diluted EPS $1.15 vs $0.49 prior year.
- Full year 2024 revenue $802.8M (+28% YoY); net income $53.5M ($1.75 diluted EPS) vs net loss in 2023.
- FY2025 guidance: revenue $940-955M (17-19% growth); diluted EPS $2.10-$2.20.
- Added 72 U.S. centers in Q4 (total 1,435); U.S. sales territories now 335; over 90,000 patients treated.
- Initiated $75M accelerated share repurchase program; operating cash flow $130.2M for full year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1609550/000160955025000009/0001609550-25-000009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1609550/000160955025000009/insp-20250210.htm
  HTML page:      https://secwatch.observer/filing/0001609550-25-000009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer